Levita, Johaina Mae B.
HRN: 26-03-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
CEFUROXIME 1.5GM (VIAL)
12/16/2024
12/18/2024
IV
1.5g
Q8h X 4 Doses
SP Primary LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes